首页> 美国卫生研究院文献>Molecular Medicine Reports >Plasma extracellular vesicle-packaged microRNAs as candidate diagnostic biomarkers for early-stage breast cancer
【2h】

Plasma extracellular vesicle-packaged microRNAs as candidate diagnostic biomarkers for early-stage breast cancer

机译:血浆细胞外囊泡包装的microRNA作为早期乳腺癌的候选诊断生物标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Extracellular vesicle-packaged microRNAs (miRNAs) are a class of circulating miRNAs located in the plasma that are packaged into extracellular vesicles. The present study examined the expression profiles of extracellular vesicles and tissue miRNAs with the aim of investigating the miRNA signatures in early-stage breast cancer. The present study identified and compared the extracellular vesicle-packaged miRNA expression signature and tissue miRNA expression signature from healthy individuals (n=10) and patients with early-stage breast cancer (n=12). A total of five miRNAs, including miRNA-375, miRNA-24-2-5p, miRNA-548b-5p, miRNA-655-3P and miRNA-376b-5p, were synchronized in extracellular vesicles and tissues of the breast cancer group when compared with the healthy group. The highest area under the curve (AUC) for a single miRNA was achieved with miRNA-548b-5p [AUC=0.785; 95% confidence interval (CI)=0.585–0.984; P=0.022]. The highest overall AUC was achieved by the combination of miRNA-375, miRNA-655-3p, miRNA-548b-5p and miRNA-24-2-5p (AUC=0.808; 95% CI=0.629–0.986; P=0.013). The Kaplan-Meier curves and log test analysis results of these five miRNAs, especially those for miRNA-548b-5p, were partly consistent with the hypothesis. Two miRNAs (miRNA-548b-5p and miRNA-376b-5p) were positively associated with patient survival, while two miRNAs (miRNA-375 and miRNA-24-2-5p) were negatively associated with patient survival. The present study provided a set of plasma extracellular vesicle-packaged miRNA-based biomarkers for the diagnosis of early-stage breast cancer.
机译:细胞外小泡包装的microRNA(miRNA)是一类位于血浆中的循环miRNA,被包装到细胞外小泡中。本研究检查了细胞外囊泡和组织miRNA的表达谱,目的是研究早期乳腺癌中的miRNA特征。本研究从健康个体(n = 10)和早期乳腺癌患者(n = 12)中鉴定并比较了细胞外小泡包装的miRNA表达特征和组织miRNA表达特征。在乳腺癌组的细胞外囊泡和组织中,总共五个miRNA,包括miRNA-375,miRNA-24-2-5p,miRNA-548b-5p,miRNA-655-3P和miRNA-376b-5p同步。与健康组相比。使用miRNA-548b-5p可以达到单个miRNA的最大曲线下面积(AUC)[AUC = 0.785; 95%置信区间(CI)= 0.585-0.984; P = 0.022]。通过组合miRNA-375,miRNA-655-3p,miRNA-548b-5p和miRNA-24-2-5p可获得最高的总AUC(AUC = 0.808; 95%CI = 0.629-0.986; P = 0.013) 。这五个miRNA的Kaplan-Meier曲线和对数检验分析结果,特别是针对miRNA-548b-5p的那些,与假说部分相符。两个miRNA(miRNA-548b-5p和miRNA-376b-5p)与患者生存呈正相关,而两个miRNA(miRNA-375和miRNA-24-2-5p)与患者生存呈负相关。本研究提供了一组血浆细胞外囊泡包装的基于miRNA的生物标记物,用于诊断早期乳腺癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号